Pancreatic Cancer Research

ResearcherGeneral Hospital of Central Theater CommandActive in the last 2 years

Weidong Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7717-8470; OpenAlex author ID A5043979648. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. LINC01857 promotes cell proliferation and migration while dampening cell apoptosis in pancreatic cancer by upregulating CDC42EP3 via miR-450b-5p. Last author DOI 10.1016/j.heliyon.2024.e38427↗
  2. Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-021-01902-0↗
  3. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-019-1436-0↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian-Xin Zhang · 1 shared paper, 2024 · strength 0.26
  2. Shuguang Wang · 2 shared papers, 2019–2021 · strength 0.21
  3. Zhonghu Li · 2 shared papers, 2019–2021 · strength 0.21
  4. Xiaowu Li · 2 shared papers, 2019–2021 · strength 0.21
  5. Yan Xiang Chen · 1 shared paper, 2021 · strength 0.12
  6. Yan Chen · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.